Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 14, 2016

View Archived Issues

EMA committee hands down positive opinion on Arzerra for relapsed CLL

Eagle Pharmaceuticals to acquire Arsia Therapeutics

European approval for Parsabiv to treat secondary hyperparathyroidism in hemodialysis patients

Combining Cas9 RNP with ssODN mediates efficient HSPC genome editing of sickle mutation

Eagle Pharmaceuticals initiates rolling NDA for Ryanodex in EHS

EMA adopts positive opinion for Novo Nordisk's Fiasp

EMA gives positive opinion on Gilead's MAA for Vemlidy

Ultragenyx Pharmaceutical withdraws conditional MAA from the EMA for Ace-ER

Recent Esteve patent describes sigma1 receptor ligands for pain

Harvard College reports insulin-degrading enzyme inhibitors

Constellation Pharmaceuticals prepares and tests LSD1 inhibitors

The Vanderbilt University discloses M1 receptor PAMs

Medshine Discovery presents JAK2 inhibitors

Interim phase I/II data presented on combination of lirilumab and nivolumab in head & neck cancer

Novel nanomedicine with alendronic acid corona shows promise for treatment of osteosarcoma

EMA's CHMP recommends approval of Suliqua

European Commission approves use of ustekinumab for Crohn's disease

Promising phase III topline results for CAM-2038 to treat moderate to severe opioid use disorder

Immune activation seen with CD122-biased cytokine NKTR-214 in cancer patients

OncBioMune updates progress in acquisition of Vitel Laboratorios

Blockade of H1R and H4R has additive effects in suppressing peanut-induced intestinal anaphylaxis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...